Previous Close | 14.76 |
Open | 14.73 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 800 |
Day's Range | 14.63 - 14.73 |
52 Week Range | 10.23 - 15.37 |
Volume | |
Avg. Volume | 310,285 |
Market Cap | 644.137M |
Beta (5Y Monthly) | 0.72 |
PE Ratio (TTM) | 9.86 |
EPS (TTM) | 1.49 |
Earnings Date | Feb 29, 2024 - Mar 04, 2024 |
Forward Dividend & Yield | 2.16 (14.63%) |
Ex-Dividend Date | Sep 28, 2023 |
1y Target Est | 15.56 |
Subscribe to Yahoo Finance Plus to view Fair Value for TRIN
Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $45 million in growth capital to Neurolens, a company commercializing innovative solutions to optimize vision.
Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity Capital" or the "Company"), a leading provider of diversified financial solutions to growth-stage companies, today announced its financial results for the quarter ended September 30, 2023.
Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $25 million in growth capital to Neuros Medical, Inc., a bioelectric technology company focused on alleviating chronic post-amputation pain and restoring quality of life.